FOLH1 as a novel biomarker for risk stratification in gastric intestinal metaplasia

doi:10.3748/wjg.118842

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 32, Issue 25

This Article

(27)

(21)

(0)

(13)

(365)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Supplementary Materials of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Gastroenterol. Jul 7, 2026; 32(25): 118842
Published online Jul 7, 2026. doi: 10.3748/wjg.118842

Full Size Figure Download Figure

Figure 2 Digital spatial profiling of formalin-fixed, paraffin-embedded samples from gastric intestinal metaplasia patients. A: Representative hematoxylin-eosin and immunofluorescence staining of regions of interest (ROIs); B: Principal component analysis for dimensionality reduction, visualizing all ROIs based on overall gene expression profiles, including the start of observation was defined as the time of the first gastroscopic biopsy [non-progression group (N)] N1-intestinal metaplasia (IM) (red color), progression group (P group) P1-IM (purple color), P2-IM (pink color), and P2-cancerous lesions (blue color). N group: Non-progression group; P group: Progression group; IF: Immunofluorescence; HE: Hematoxylin-eosin; PanCK: Pan-cytokeratin; CD: Cluster of differentiation; CTR: Containing normal tissue; IM: Intestinal metaplasia.

Citation: He S, Guo XF, Wang Y, Bai JQ, Wang JP, Shi JH, Shi YY, Yuan J, Wei W, Yang Y, Shi XH, Feng Y, Ding X, Gao W, Lu D, Zhou WX, Zhang P. FOLH1 as a novel biomarker for risk stratification in gastric intestinal metaplasia. World J Gastroenterol 2026; 32(25): 118842
URL: https://www.wjgnet.com/1007-9327/full/v32/i25/118842.htm
DOI: https://dx.doi.org/10.3748/wjg.118842

He S, Guo XF, Wang Y, Bai JQ, Wang JP, Shi JH, Shi YY, Yuan J, Wei W, Yang Y, Shi XH, Feng Y, Ding X, Gao W, Lu D, Zhou WX, Zhang P. FOLH1 as a novel biomarker for risk stratification in gastric intestinal metaplasia. World J Gastroenterol 2026; 32(25): 118842 [DOI: 10.3748/wjg.118842]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.